Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Oligonucleotides
Sort By
Newest First
Sign in
1 / 1
1 / 1
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05
Feb 01, 2023
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06
Oct 11, 2022
Expanded Capacity
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
WuXi STA
PR-M01-20-NI-010
Jan 07, 2020
Oligonucleotides
Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs
Bill Jarvis; Brendan Nichols
CRB USA
PAP-Q4-18-CL-002
Oct 26, 2018
Strategic Partnership
New Collaboration Targets the Development of Oligonucleotides
Nigel Walker
Nice Insight
PAO-M12-17-NI-002
Dec 01, 2017
